Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment

Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment

Source: 
Stat
snippet: 

An experimental pill from Viking Therapeutics (VKTX) reduced liver fat in patients with early signs of fatty liver disease, according to results from a mid-stage clinical trial announced Tuesday.